LEXX
Price
$0.90
Change
+$0.04 (+4.65%)
Updated
Jul 3 closing price
Capitalization
17.6M
14 days until earnings call
PDSB
Price
$1.33
Change
+$0.06 (+4.72%)
Updated
Jul 3 closing price
Capitalization
60.79M
40 days until earnings call
Interact to see
Advertisement

LEXX vs PDSB

Header iconLEXX vs PDSB Comparison
Open Charts LEXX vs PDSBBanner chart's image
Lexaria Bioscience
Price$0.90
Change+$0.04 (+4.65%)
Volume$31.06K
Capitalization17.6M
PDS Biotechnology
Price$1.33
Change+$0.06 (+4.72%)
Volume$141.46K
Capitalization60.79M
LEXX vs PDSB Comparison Chart in %
Loading...
LEXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LEXX vs. PDSB commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LEXX is a StrongBuy and PDSB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (LEXX: $0.90 vs. PDSB: $1.33)
Brand notoriety: LEXX and PDSB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LEXX: 28% vs. PDSB: 24%
Market capitalization -- LEXX: $17.6M vs. PDSB: $60.79M
LEXX [@Biotechnology] is valued at $17.6M. PDSB’s [@Biotechnology] market capitalization is $60.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LEXX’s FA Score shows that 0 FA rating(s) are green whilePDSB’s FA Score has 0 green FA rating(s).

  • LEXX’s FA Score: 0 green, 5 red.
  • PDSB’s FA Score: 0 green, 5 red.
According to our system of comparison, PDSB is a better buy in the long-term than LEXX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LEXX’s TA Score shows that 4 TA indicator(s) are bullish while PDSB’s TA Score has 5 bullish TA indicator(s).

  • LEXX’s TA Score: 4 bullish, 4 bearish.
  • PDSB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both LEXX and PDSB are a good buy in the short-term.

Price Growth

LEXX (@Biotechnology) experienced а +4.70% price change this week, while PDSB (@Biotechnology) price change was -8.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

LEXX is expected to report earnings on Oct 29, 2025.

PDSB is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PDSB($60.8M) has a higher market cap than LEXX($17.6M). PDSB YTD gains are higher at: -18.405 vs. LEXX (-57.143). LEXX has higher annual earnings (EBITDA): -9.32M vs. PDSB (-33.08M). PDSB has more cash in the bank: 40M vs. LEXX (6.54M). LEXX has less debt than PDSB: LEXX (124K) vs PDSB (19M). LEXX has higher revenues than PDSB: LEXX (526K) vs PDSB (0).
LEXXPDSBLEXX / PDSB
Capitalization17.6M60.8M29%
EBITDA-9.32M-33.08M28%
Gain YTD-57.143-18.405310%
P/E RatioN/AN/A-
Revenue526K0-
Total Cash6.54M40M16%
Total Debt124K19M1%
FUNDAMENTALS RATINGS
LEXX vs PDSB: Fundamental Ratings
LEXX
PDSB
OUTLOOK RATING
1..100
274
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
34
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
9364
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9532

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PDSB's Valuation (34) in the Pharmaceuticals Major industry is in the same range as LEXX (37) in the null industry. This means that PDSB’s stock grew similarly to LEXX’s over the last 12 months.

PDSB's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as LEXX (100) in the null industry. This means that PDSB’s stock grew similarly to LEXX’s over the last 12 months.

PDSB's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as LEXX (99) in the null industry. This means that PDSB’s stock grew similarly to LEXX’s over the last 12 months.

PDSB's Price Growth Rating (64) in the Pharmaceuticals Major industry is in the same range as LEXX (93) in the null industry. This means that PDSB’s stock grew similarly to LEXX’s over the last 12 months.

PDSB's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as LEXX (100) in the null industry. This means that PDSB’s stock grew similarly to LEXX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LEXXPDSB
RSI
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
86%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 4 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
LEXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PDSB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FMANF0.10N/A
+0.65%
Freeman Gold Corp.
CHUEF12.67N/A
N/A
Chubu Electric Power
RBNK23.99N/A
N/A
RiverBank Holding Company
MNOIY21.95N/A
N/A
Mandarin Oriental International Ltd.
FNCSF5.10N/A
N/A
North American Financial 15 Split Corp

LEXX and

Correlation & Price change

A.I.dvisor tells us that LEXX and PDSB have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LEXX and PDSB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LEXX
1D Price
Change %
LEXX100%
+5.24%
PDSB - LEXX
30%
Poorly correlated
+4.72%
OCUL - LEXX
29%
Poorly correlated
+1.69%
MIST - LEXX
28%
Poorly correlated
+1.04%
BTAI - LEXX
27%
Poorly correlated
N/A
STRO - LEXX
27%
Poorly correlated
-0.10%
More

PDSB and

Correlation & Price change

A.I.dvisor indicates that over the last year, PDSB has been loosely correlated with ARCT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PDSB jumps, then ARCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PDSB
1D Price
Change %
PDSB100%
+4.72%
ARCT - PDSB
49%
Loosely correlated
+1.17%
RXRX - PDSB
48%
Loosely correlated
+1.15%
DYN - PDSB
45%
Loosely correlated
-2.01%
ATOS - PDSB
45%
Loosely correlated
+1.43%
NRIX - PDSB
44%
Loosely correlated
+2.33%
More